Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07009977 · ClinicalTrials.gov registry record · NA
Project BrEAtHe: A Culturally Tailored MBSR Intervention for Young Adult Black Men
A NA study, sponsored by UConn Health.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT07009977: Clinical Trial NA study, sponsored by UConn Health.
NCT07009977 is a NA study that was terminated before completion, run by UConn Health. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07009977, a NA study, was terminated before completion, sponsored by UConn Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to create a program focused on mindfulness and stress reduction specifically tailored to young adult Black males.
Primary Outcome
Daily marijuana use will be assessed with ecological momentary assessment (EMA). Participants will be asked to respond to random digital prompts on a handheld mobile device about recent substance use. Questions will include "Within the past hour, have you: (used marijuana)?" The response anchors for these questions will be "NO" or "YES." To classify alcohol or marijuana use confirmed with a "YES" response as problematic, The Drug Abuse Screening Test (DAST-10) will be administered. A separate su
Interventions
- BEHAVIORAL self-guided mHealth app only
- BEHAVIORAL self-guided mHealth app + 'real-time' feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-09-27 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
Why NCT07009977 stopped before completion
NCT07009977 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which self-guided mHealth app only is the first listed.
NCT07009977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07009977 about?
NCT07009977 is a clinical study titled "Project BrEAtHe: A Culturally Tailored MBSR Intervention for Young Adult Black Men". The purpose of this study is to create a program focused on mindfulness and stress reduction specifically tailored to young adult Black males.
What is the current status of trial NCT07009977?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2023-09-27. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT07009977?
The interventions under investigation include: self-guided mHealth app only (BEHAVIORAL), self-guided mHealth app + 'real-time' feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT07009977?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07009977's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI